Siemens Healthineers and Biogen announced today that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has been at the forefront of delivering therapies to MS patients.
iMDsoft®, a leader in clinical information systems, announced that they have been awarded a position on the NHS London Procurement Partnership Clinical and Digital Information Systems (CDIS) framework for Lot 1 - Electronic Patient Record Systems. iMDsoft's clinical EPR solution, MetaVision, offers hospital-wide electronic patient records and includes support for clinical workflow management and decision support,
CHU de Charleroi, is a large, multi-site public hospital organisation based in Belgium's fifth biggest city. It has 1,424 beds and almost 5,000 members of staff, working in most medical and surgical disciplines. In line with its aim to provide high quality care and a superior experience to all patients, CHU de Charleroi is working with Carestream Health to ensure patient information, including multimedia clinical objects, can be shared securely and reliably across its sites and with authorised external parties.
Agfa HealthCare announces has signed a new agreement with The Ipswich Hospital NHS Trust to transition to the integrated Enterprise Imaging for Radiology platform, helping the Trust achieve its clinical and integration goals.
Ipswich Hospital is a district general hospital in Suffolk, England, providing a wide range of services to the population of East Suffolk. With around 800 beds, it serves a catchment area of approximately 360,000 people.
Autism, diabetes, cancer and pain are among the topics for the €348 million 10th Call for proposals launched under the IMI2 programme. Other topics in the Call focus on: the creation of a European network for clinical trials in children; the biomanufacture of certain medicines; the need to include the patient perspective in medicines development; and the role of certain genes in disease.
Royal Philips (NYSE: PHG, AEX: PHIA), a leader in integrated image-guided therapy solutions, today announced the development of an industry-first augmented-reality surgical navigation technology that is designed to help surgeons perform image-guided open and minimally-invasive spine surgery.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc. (NASDAQ:ILMN), the global leader in DNA sequencing and array-based technologies, have announced a strategic collaboration that aims to integrate Illumina's sequencing systems for large-scale analysis of genetic variation and function and Philips' IntelliSpace Genomics clinical informatics platform,